Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Leucemia mieloidea")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 4706

  • Page / 189
Export

Selection :

  • and

Epipodophyllotoxin-related acute myeloid leukaemiaCHING-HON PUI.Lancet (British edition). 1991, Vol 338, Num 8780, issn 0140-6736, p. 1468Article

Detection of residual bcr/abl translocation by polymerase chain reaction in chronic myeloid leukaemia patients after bone-marrow transplantationGABERT, J; LAFAGE, M; MARANINCHI, D et al.Lancet (British edition). 1989, Vol 2, Num 8672, pp 1125-1128, issn 0140-6736, 4 p.Article

Skeletal scintigraphy of multiple bone infarctionsADCOCK, K. A; ROTH, J. C.Clinical nuclear medicine. 1989, Vol 14, Num 11, pp 852-853, issn 0363-9762, 2 p.Article

Important therapeutic targets in chronic myelogenous leukemiaKANTARJIAN, Hagop M; GILES, Francis; QUINTAS-CARDAMA, Alfonso et al.Clinical cancer research. 2007, Vol 13, Num 4, pp 1089-1097, issn 1078-0432, 9 p.Article

Cigarette smoking, blast crisis, and survival in chronic myeloid leukemiaHERR, R; FERGUSON, J; MYERS, N et al.American journal of hematology. 1990, Vol 34, Num 1, pp 1-4, issn 0361-8609Article

Traitement de la leucémie myéloïde chronique en 2006REA, Delphine.Hématologie (Montrouge). 2006, Vol 12, pp 4-10, issn 1264-7527, 7 p., NS5Article

Therapy associated leukaemiaDEVEREUX, S.Blood reviews. 1991, Vol 5, Num 3, pp 138-145, issn 0268-960XArticle

Molecular elimination of the minimal residual Ph1 clone with IFNα in CMLOGUMA, N; SHIEGETA, C; TAKAUCHI, K et al.Lancet (British edition). 1992, Vol 339, Num 8792, pp 557-558, issn 0140-6736Article

Philadelphia-negative (Ph-) chronic myeloid leukemia (CML) : comparison with Ph+ CML and chronic myelomonocytic leukemiaMARTIAT, P; MICHAUX, J. L; RODHAIN, J et al.Blood. 1991, Vol 78, Num 1, pp 205-211, issn 0006-4971Article

CML: Molecular Mechanisms & Therapeutic StrategiesARLINGHAUS, Ralph B.Oncogene (Basingstoke). 2002, Vol 21, Num 56, issn 0950-9232, 141 p., NS7Serial Issue

Juvenile chronic myelogenous leukemiaFREEDMAN, M. H; ESTROV, Z; CHAN, H. S. L et al.The American journal of pediatric hematology/oncology. 1988, Vol 10, Num 3, pp 261-267, issn 0192-8562Article

Leucémie myéloïde chronique dans l'évolution d'une sarcoïdose = Chronic myelocytic leukaemia in the course of sarcoidosisKROSI, Z; CASASSUS, P; VALEYRE, D et al.Revue de pneumologie clinique (Paris). 1988, Vol 44, Num 1, pp 33-35, issn 0761-8417Article

Chronic myelogenous leukemia (CML) : resistance to tyrosine kinase inhibitorsHOCHHAUS, A.Annals of oncology. 2006, Vol 17, issn 0923-7534, x274-x279, SUP10Conference Paper

A sequential blockade strategy for the design of combination therapies to overcome oncogene addiction in chronic myelogenous leukemiaRONG CHEN; GANDHI, Varsha; PLUNKETT, William et al.Cancer research (Baltimore). 2006, Vol 66, Num 22, pp 10959-10966, issn 0008-5472, 8 p.Article

TGF-β-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemiaNAKA, Kazuhito; HOSHII, Takayuki; MURAGUCHI, Teruyuki et al.Nature (London). 2010, Vol 463, Num 7281, pp 676-680, issn 0028-0836, 5 p.Article

Leucémie myéloïde chronique : diagnostic, traitement = Chronic myeloid leukaemiaGUILHOT, F.La Revue du praticien (Paris). 1993, Vol 43, Num 17, pp 2263-2268, issn 0035-2640Article

False-positive flow cytometric platelet glycoprotein IIb/IIIa expression in myeloid leukemias secondary to platelet adherence to blastsBETZ, S. A; FOUCAR, K; HEAD, D. R et al.Blood. 1992, Vol 79, Num 9, pp 2399-2403, issn 0006-4971Article

Spurious anoxaemia in a patient with chronic myeloid leukaemiaWONG, K. F; LEUNG, V. K. M; MA, S. K et al.Clinical and laboratory haematology. 1992, Vol 14, Num 3, pp 263-264, issn 0141-9854Article

Effect of hydroxyurea on blood viscosity in chronic myelogenous leukemia with hyperleukocytosisKAILASH SHARMA; SUCHITRA RAO; BHAT, S. V et al.Physiological chemistry and physics and medical NMR. 1991, Vol 23, Num 4, pp 261-268, issn 0748-6642Article

Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon α-2b alone or in combination with interferon γOPALKA, B; WANDL, U. B; BECHER, R et al.Blood. 1991, Vol 78, Num 9, pp 2188-2193, issn 0006-4971Article

Thymidine kinase in human leukemia ― expression of three isoenzyme variants in six patients with chronic myelocytic leukemiaMUNCH-PETERSEN, B.Leukemia research. 1990, Vol 14, Num 1, pp 39-45, issn 0145-2126Article

History of the treatment of chronic myelocytic leukemiaSEARS, D. A.The American journal of the medical sciences. 1988, Vol 296, Num 2, pp 85-86, issn 0002-9629Article

Excretion of hydroxuyrea into milkSYLVESTER, R. K; LOBELL, M; TERESI, M. E et al.Cancer. 1987, Vol 60, Num 9, pp 2177-2178, issn 0008-543XArticle

A quantitative study of eosinophil polymorphonuclear leucocytes in granulocytic sarcoma (chloroma)MULLER, S; CROCKER, J; SMITH, P. J et al.Journal of clinical pathology. 1987, Vol 40, Num 10, issn 0021-9746, 1264Article

Advances in the treatment of haematological malignancies : optimal sequence of CML treatmentHOCHHAUS, A.Annals of oncology. 2007, Vol 18, issn 0923-7534, ix58-ix63, SUP9Conference Paper

  • Page / 189